BioMarin Pharmaceutical Inc. (BMRN) Reports Q1 Loss of $0.04
Tweet
Share
E-mailGet Alerts BMRN Hot Sheet
Price: $68.53 -2.43%
Financial Fact:
NET INCOME (LOSS) PER SHARE, BASIC: -0.26
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
NET INCOME (LOSS) PER SHARE, BASIC: -0.26
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) reported Q1 EPS of ($0.04), $0.06 better than the analyst estimate of ($0.10). Revenue for the quarter came in at $109.46 million versus the consensus estimate of $103.8 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BioMarin Pharmaceutical Inc. (BMRN) PT Raised to $114 at Canaccord
- KinderCare Learning Companies, Inc. (KLC) Misses Q2 EPS by 2c; Offers Guidance
- Birchtech Corp. (BCHT) Misses Q2 EPS by 7c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
